title: Duchenne Muscular Dystrophy Drugs Market Global Forecast 2025-2032: Sarepta, Pfizer, BioMarin, Roche, Bayer, Solid Biosciences, Cytokinetics, and NS Pharma Drive Innovation and Commercial Expansion
source: Yahoo
date: 2025-10-09
url: https://finnhub.io/api/news?id=f6026150ecd01b4acbfdaf99b1460c761ca2a6b4fc5a5277684b57390b3f35ad
The Duchenne Muscular Dystrophy Drugs Market presents opportunities in advanced genetic therapies, digital health, and adaptive models amid rising global demand. Strategic alliances, resilient supply chains, and localized strategies are key in navigating regulatory shifts and achieving competitive differentiation in diverse regions. Duchenne Muscular Dystrophy Drugs Market Duchenne Muscular Dystrophy Drugs Market Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs Ma
